Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Stock Markets Analysis & Opinion

Contribute
Edison
Cohort: Agile And Responsive   By Edison - Dec 13, 2017

Cohort (LON:CHRT) continues to make progress in a tough UK defence trading environment. Our earnings forecasts remain largely unchanged as performances at MASS and EID continue ahead of expectations,...

Zacks Investment Research
PBM Industry Shows Strength: 3 Stocks In Focus By Zacks Investment Research - Dec 13, 2017

The role of pharmacy benefit managers (PBM) in the U.S. healthcare sector has been evolving. From being just third-party administrators of prescription drug programs, PBMs have come a long way. PBMs...

Petros Steriotis
DAX Flirting With A Breakout By Petros Steriotis - Dec 13, 2017

DAX flirting with a breakout that would then target the all-time high Original post

London Capital Group
Moore Problems And Dixons Subpar-Phone Sales By London Capital Group - Dec 13, 2017

Republican Roy Moore has lost his Alabama Senate seat-Dixons Carphone PLC (LON:DC)shares rally on mobile unit plans -Tui AG NA (DE:TUIGn)shares rise after own-brand hotel sales outstrip airline...

Zacks Investment Research
Clean Power Plan Rollback To Hit Alternative Energy Stocks By Zacks Investment Research - Dec 13, 2017

President Trump’s plans to shift focus to traditional energy businesses such as coal, oil and gas and his skepticism around global climate change have cast a shadow over the future of solar...

LiteForex Europe
CAC: Wednesday's Technical Analysis By LiteForex Europe - Dec 13, 2017

CAC, D1On the daily chart, the instrument is trading in the upper Bollinger band. The price remains just above its moving averages that are directed up. The RSI is testing from below its longer MA....

Jason Sen
Emini S&P: All Time High At 2670.25 By Jason Sen - Dec 13, 2017

Emini S&P all time high at 2670.25 is exactly at the important 6.5 year trend line resistance at 2665/2675. Nothing else matters in this contract. Bulls need a clear weekly close above here on...

Zacks Investment Research
3 Stocks To Buy On Skyrocketing 2018 Profits By Zacks Investment Research - Dec 13, 2017

As we head into 2018, many investors are beginning to evaluate their investment portfolios and make adjustments. But one thing that is unlikely to change in the New Year is the hunt for companies that...

Technical Trading
Forex, Dow Jones Levels: December 13, 2017 By Technical Trading - Dec 13, 2017

EUR/CHFToday’s support: - 1.1616(main), where correction is possible. Break would give 1.1593, where correction also may be. Then follows 1.1564. Break of the latter would result 1.43. If a...

Zacks Investment Research
Lindsay (LNN) Downgraded To Sell On Near-Term Headwinds By Zacks Investment Research - Dec 13, 2017

On Dec 13, Lindsay Corporation (NYSE:LNN) was downgraded to a Zacks Rank #4 (Sell).The downgrade underlines negative estimate revisions following the disappointing fourth-quarter fiscal 2017 results...

Zacks Investment Research
Is Apple The Republican Tax Plan's Biggest Winner? By Zacks Investment Research - Dec 13, 2017

The House and the Senate are getting close to reconciling their respective tax bills, with lawmakers and congressional staffers pulling all-nighters to try revise key aspects of the legislation. For...

Zacks Investment Research
After A Weak 2017, Can Dollar ETFs Rebound In 2018? By Zacks Investment Research - Dec 13, 2017

The king dollar has completely lost its stature in 2017 on geopolitical tension and uncertainty regarding the passing of President Donald Trump’s proposed policies. Even two rate hikes by the...

Zacks Investment Research
Alternative Energy Shines On Renewed Hopes, Investments By Zacks Investment Research - Dec 13, 2017

Despite the uncertainty related to U.S. tax policy or commitment to fight climate change, the momentum achieved by the renewable energy sector is unlikely to subside.Contracts from small- to...

Zacks Investment Research
Allergan Inks Deal To Buy Texas-Based Repros Therapeutics By Zacks Investment Research - Dec 13, 2017

Irish pharma giant Allergan plc (NYSE:AGN) has recently inked a definitive agreement to acquire a Texas-based development stage biopharmaceutical company, Repros Therapeutics (NASDAQ:RPRX) . Repros...

Continue with Apple
Continue with Google
or
Sign up with Email